Gilead Sciences (GILD) Earnings (2008 - 2026)
Gilead Sciences (GILD) earnings from Jun 30, 2008 to Mar 31, 2026. The TTM Gilead Sciences (GILD) earnings is $9.22B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Gilead Sciences (GILD) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +54.50% |
| 3 Years TTM | +18.18% |
| 5 Years TTM | +98.24% |
| 10 Years TTM | -6.13% |
| All Time TTM | +10.79% |
Annual Earnings change of Gilead Sciences (GILD)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $2.02B | -76.25% |
| 2025 | $8.51B | +1672.92% |
| 2024 | $480M | -91.53% |
| 2023 | $5.67B | +23.37% |
| 2022 | $4.59B | -26.23% |
| 2021 | $6.22B | +4960.98% |
| 2020 | $123M | -97.72% |
| 2019 | $5.39B | -1.26% |
| 2018 | $5.46B | +17.87% |
| 2017 | $4.63B | -65.72% |
| 2016 | $14B | -25.44% |
| 2015 | $18B | +49.64% |
| 2014 | $12B | +293.53% |
| 2013 | $3.08B | +18.63% |
| 2012 | $2.59B | -7.55% |
| 2011 | $2.80B | -3.36% |
| 2010 | $2.90B | +10.07% |
| 2009 | $2.64B | +33.19% |
| 2008 | $1.98B | +24.86% |
| 2007 | $1.58B | N/A |
Comparison Gilead Sciences (GILD) five years earnings CAGR with competitors
Gilead Sciences (GILD) five years earnings CAGR is 98.24%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| LLY | Lilly(Eli) & Company | 32.92% | -66.49% |
| NVO | Novo Nordisk | 23.10% | -76.48% |
| AZN | Astrazeneca plc | 21.17% | -78.45% |
| NVS | Novartis AG | 11.21% | -88.59% |
| JNJ | Johnson & Johnson | 6.84% | -93.04% |
| MRK | Merck & Co Inc | 4.92% | -94.99% |
| GSK | GSK Plc | 2.84% | -97.11% |
| AMGN | AMGEN Inc | 1.94% | -98.02% |